Showing results (1-10 of 78) with videos related to
Sort By:
Pageof 8
Expert Opinion on Biological Therapy|March 21, 2008
Immunotherapy for gastrointestinal cancer: current status and strategies for improving efficacyEyad Elkord, Robert E Hawkins, Peter L SternCancer Treatment Reviews|October 31, 2006
Anti-angiogenic therapy in the treatment of advanced renal cell cancerRuth E Board, Fiona C Thistlethwaite, Robert E HawkinsBiodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|October 7, 2005
Toward personalized immunotherapy for non-Hodgkin lymphoma: targeting the idiotypic immunoglobulinAnne C Armstrong, Eleanor J Cheadle, Robert E HawkinsBritish Journal of Haematology|May 15, 2008
The combination of cyclophosphamide and human T cells genetically engineered to target CD19 can eradicate established B-cell lymphomaEleanor J Cheadle, David E Gilham, Robert E HawkinsCancer Immunology, Immunotherapy : CII|December 10, 2014
Overcoming the toxicity hurdles of genetically targeted T cellsMonica Casucci, Robert E Hawkins, Gianpietro Dotti, et al.Clinical Immunology (Orlando, Fla.)|May 17, 2011
Expanded subpopulation of FoxP3+ T regulatory cells in renal cell carcinoma co-express Helios, indicating they could be derived from natural but not induced TregsEyad Elkord, Smita Sharma, Deborah J Burt, et al.Therapeutic Advances in Vaccines and Immunotherapy|July 3, 2020
Transgenic T-cell receptor immunotherapy for cancer: building on clinical successNatasha Oppermans, Gray Kueberuwa, Robert E Hawkins, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 22, 2009
T cell-based immunotherapy of metastatic renal cell carcinoma: modest success and future perspectiveAlaaeldin Shablak, Robert E Hawkins, Dominic G Rothwell, et al.British Medical Bulletin|August 15, 2002
Cancer vaccines and immunotherapySaid Dermime, Anne Armstrong, Robert E Hawkins, et al.Current Opinion in Molecular Therapeutics|March 1, 2005
Engineering T-cells with antibody-based chimeric receptors for effective cancer therapyFiona Thistlethwaite, Wasat Mansoor, David E Gilham, et al.Pageof 8